Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
IVZ Stock Forecast 2025-2026
$14.72
Current Price
$6.50B
Market Cap
Buy 2
Hold 11
Sell 1
Wall St Analyst Ratings
Distance to IVZ Price Targets
+18.9%
To High Target of $17.50
+1.9%
To Median Target of $15.00
-4.9%
To Low Target of $14.00
IVZ Price Momentum
+1.3%
1 Week Change
-2.9%
1 Month Change
-1.5%
1 Year Change
-15.8%
Year-to-Date Change
-24.7%
From 52W High of $19.55
+26.9%
From 52W Low of $11.60
📊 TOP ANALYST CALLS
Did IVZ Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Invesco is one of their latest high-conviction picks.
Latest IVZ Stock Price Targets & Analyst Predictions
Based on our analysis of 25 Wall Street analysts, IVZ has a neutral consensus with a median price target of $15.00 (ranging from $14.00 to $17.50). The overall analyst rating is Buy (6.1/10). Currently trading at $14.72, the median forecast implies a 1.9% upside. This outlook is supported by 2 Buy, 11 Hold, and 1 Sell ratings.
The most optimistic forecast comes from Michael Brown at Wells Fargo, projecting a 18.9% upside. Conversely, the most conservative target is provided by Benjamin Budish at Barclays, suggesting a 4.9% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
IVZ Analyst Ratings
2
Buy
11
Hold
1
Sell
IVZ Price Target Range
Low
$14.00
Average
$15.00
High
$17.50
Current: $14.72
Latest IVZ Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for IVZ.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jun 12, 2025 | Goldman Sachs | Alexander Blostein | Neutral | Maintains | $16.25 |
| Jun 9, 2025 | Barclays | Benjamin Budish | Equal-Weight | Maintains | $15.00 |
| Apr 23, 2025 | Goldman Sachs | Alexander Blostein | Neutral | Maintains | $15.25 |
| Apr 23, 2025 | Evercore ISI Group | Glenn Schorr | In-Line | Maintains | $15.00 |
| Apr 23, 2025 | Barclays | Benjamin Budish | Equal-Weight | Maintains | $14.00 |
| Apr 17, 2025 | Morgan Stanley | Michael Cyprys | Equal-Weight | Maintains | $15.00 |
| Apr 16, 2025 | JP Morgan | Kenneth Worthington | Neutral | Maintains | $16.00 |
| Apr 16, 2025 | Barclays | Benjamin Budish | Equal-Weight | Maintains | $13.00 |
| Apr 14, 2025 | Goldman Sachs | Alexander Blostein | Neutral | Maintains | $15.00 |
| Apr 11, 2025 | Evercore ISI Group | Glenn Schorr | In-Line | Maintains | $13.00 |
| Apr 9, 2025 | TD Cowen | Bill Katz | Hold | Downgrade | $13.00 |
| Apr 8, 2025 | Wells Fargo | Michael Brown | Underweight | Maintains | $14.50 |
| Apr 3, 2025 | B of A Securities | Michael Carrier | Neutral | Maintains | $18.00 |
| Apr 3, 2025 | Goldman Sachs | Alexander Blostein | Neutral | Maintains | $17.00 |
| Mar 31, 2025 | Citigroup | Christopher Allen | Neutral | Maintains | $16.00 |
| Feb 6, 2025 | Morgan Stanley | Michael Cyprys | Equal-Weight | Maintains | $19.00 |
| Feb 3, 2025 | UBS | Brennan Hawken | Neutral | Maintains | $21.00 |
| Jan 29, 2025 | Goldman Sachs | Alexander Blostein | Neutral | Maintains | $20.75 |
| Jan 29, 2025 | BMO Capital | Etienne Ricard | Market Perform | Maintains | $21.00 |
| Jan 29, 2025 | Barclays | Benjamin Budish | Equal-Weight | Maintains | $20.00 |
Invesco Ltd. (IVZ) Competitors
The following stocks are similar to Invesco based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Invesco Ltd. (IVZ) Financial Data
Invesco Ltd. has a market capitalization of $6.50B with a P/E ratio of 11.6x. The company generates $6.12B in trailing twelve-month revenue with a 13.1% profit margin.
Revenue growth is +3.7% quarter-over-quarter, while maintaining an operating margin of +18.1% and return on equity of +5.1%.
Valuation Metrics
Market Cap
$6.50B
Enterprise Value
$11.74B
P/E Ratio
11.6x
PEG Ratio
7.7x
Price/Sales
1.1x
Growth & Margins
Revenue Growth (YoY)
+3.7%
Gross Margin
+36.3%
Operating Margin
+18.1%
Net Margin
+13.1%
EPS Growth
+14.7%
Financial Health
Cash/Price Ratio
+12.5%
Current Ratio
0.7x
Debt/Equity
6.1x
ROE
+5.1%
ROA
+2.4%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Invesco Ltd. (IVZ) Business Model
About Invesco Ltd.
What They Do
Global investment management company offering diverse solutions.
Business Model
Invesco Ltd. generates revenue through fees from managing a wide range of investment portfolios, including mutual funds, ETFs, and pension plans. The firm caters to both institutional and individual clients, focusing on delivering tailored investment strategies that align with clients' financial objectives across various asset classes.
Additional Information
Headquartered in Atlanta, Georgia, Invesco emphasizes innovative strategies and risk management, leveraging extensive research and a team of experienced portfolio managers. The company plays a significant role in the global financial markets, impacting key sectors such as healthcare, technology, and finance.
Company Information
Sector
Financial Services
Industry
Asset Management
Employees
8,495
CEO
Mr. Andrew Ryan Schlossberg
Country
United States
IPO Year
1995
Website
www.invesco.comInvesco Ltd. (IVZ) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
BlackRock Rides on Private Market Growth: Is Now the Time to Buy BLK?
BLK eyes $400B in private markets by 2030, but rising costs and global risks may test its growth push. Is it a lucrative bet now?
Jun 17, 2025
By Ronit Masi
Analyst Blog
Invesco's May AUM Climbs 5.6% on Strong Markets, Shares Up 1.8%
IVZ's AUM increases 5.6% in May to $1.94 trillion on strong market returns and inflows, lifting shares by 1.8%.
Jun 12, 2025
By Zacks Equity Research
Analyst Blog
Latest News
Quick Summary
The news excerpt discusses the complexities of reaching retirement age in the U.S., highlighting potential challenges and benefits for individuals entering this phase.
Why It Matters
Concerns about retirement age implications may influence consumer spending and investment strategies, affecting market performance and economic stability.
Source: 24/7 Wall Street
Market Sentiment:
Positive
Quick Summary
Invesco (IVZ) reported a 5.6% increase in assets under management (AUM) to $1.94 trillion in May, driven by strong market returns and inflows, resulting in a 1.8% rise in shares.
Why It Matters
IVZ's rising AUM and strong market performance indicate robust growth potential, likely enhancing shareholder value and investor confidence in future earnings.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Invesco Ltd. (NYSE: IVZ) reported preliminary assets under management of $1,942.7 billion for June 2025, reflecting a 5.6% increase from the previous month.
Why It Matters
Invesco's 5.6% increase in assets under management signals strong investor confidence and potential revenue growth, positively impacting its stock performance and market position.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Invesco Ltd. CFO Allison Dukes will speak at the Morgan Stanley U.S. Financials Conference on June 3, 2025, at 11:25 a.m. ET.
Why It Matters
Allison Dukes' participation signals Invesco's transparency and engagement with investors, potentially influencing market perception and stock performance.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Eighteen of twenty-four 'safer' low-priced Dividend Dogs are fair-priced, with top ten GVAS stocks projected to yield 17.99% to 68.74% net gains by May 2026, at 29% lower risk than the market.
Why It Matters
The analysis highlights undervalued large-cap stocks with strong potential returns and lower risk, appealing to income-focused investors seeking growth in a volatile market.
Source: Seeking Alpha
Market Sentiment:
Positive
Quick Summary
Invesco Ltd. CEO Andrew Schlossberg will speak at the Bernstein Strategic Decisions Conference on May 20, 2025, at 1:30 p.m. ET.
Why It Matters
Andrew Schlossberg's participation in a prominent conference may signal strategic insights and direction for Invesco, potentially impacting investor confidence and stock performance.
Source: PRNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About IVZ Stock
What is Invesco Ltd.'s (IVZ) stock forecast for 2025?
Based on our analysis of 25 Wall Street analysts, Invesco Ltd. (IVZ) has a median price target of $15.00. The highest price target is $17.50 and the lowest is $14.00.
Is IVZ stock a good investment in 2025?
According to current analyst ratings, IVZ has 2 Buy ratings, 11 Hold ratings, and 1 Sell ratings. The stock is currently trading at $14.72. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for IVZ stock?
Wall Street analysts predict IVZ stock could reach $15.00 in the next 12 months. This represents a 1.9% increase from the current price of $14.72. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Invesco Ltd.'s business model?
Invesco Ltd. generates revenue through fees from managing a wide range of investment portfolios, including mutual funds, ETFs, and pension plans. The firm caters to both institutional and individual clients, focusing on delivering tailored investment strategies that align with clients' financial objectives across various asset classes.
What is the highest forecasted price for IVZ Invesco Ltd.?
The highest price target for IVZ is $17.50 from Michael Brown at Wells Fargo, which represents a 18.9% increase from the current price of $14.72.
What is the lowest forecasted price for IVZ Invesco Ltd.?
The lowest price target for IVZ is $14.00 from Benjamin Budish at Barclays, which represents a -4.9% decrease from the current price of $14.72.
What is the overall IVZ consensus from analysts for Invesco Ltd.?
The overall analyst consensus for IVZ is neutral. Out of 25 Wall Street analysts, 2 rate it as Buy, 11 as Hold, and 1 as Sell, with a median price target of $15.00.
How accurate are IVZ stock price projections?
Stock price projections, including those for Invesco Ltd., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 19, 2025 11:14 PM UTC